Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

Documenti analoghi

• Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
  di: Wallecha, Anu, et al.
  Pubblicazione: (2014)
• Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy
  di: Mkrtichyan, Mikayel, et al.
  Pubblicazione: (2013)
• Lm-LLO-Based Immunotherapies and HPV-Associated Disease
  di: Anu Wallecha, et al.
  Pubblicazione: (2012-01-01)
• Lm-LLO-Based Immunotherapies and HPV-Associated Disease
  di: Wallecha, Anu, et al.
  Pubblicazione: (2012)
• Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy
  di: Molli, Poonam, et al.
  Pubblicazione: (2013)